CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 160 target
Drug / intervention
Metoclopramide (Maxolon) +1 moredrug
Likely dose
Metoclopramide (Maxolon) 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00477776
NCT00477776Phase 3Completed
CompareCT.gov

Metoclopramide to Improve Lactogenesis II in Diabetic Women: a Randomized Controlled Trial

National University Hospital, Singapore·interventional·Posted May 24, 2007·Updated Sep 21, 2009

In Brief

A Phase 3 clinical trial evaluating Metoclopramide (Maxolon) and Placebo for Breastfeeding. Completed, enrolled 160 participants across 1 site.

Detailed Summary

Early use of oral maxalon can hasten and improve the establishment of breastfeeding in diabetic mothers after preterm and term deliveries. Maxolon promotes breastfeeding by working on the central nervous system which increases the milk producing hormone, prolactin which in turn helps to increase the milk supply for breastfeeding. Successful early breastfeeding establishment is important for continued breastfeeding.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreastfeeding
CountriesSingapore
CollaboratorsThe University of Western Australia

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 24, 2007
Enrollment StartApr 1, 2006
Primary CompletionSep 1, 2008
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 19.1 years ago

Interventions

Metoclopramide (Maxolon)drug

Metoclopramide 10 mg 3 times a day for 7 days, 2 times a day from day 8 to day 10, once a day for day 11 and 12

Placebodrug

Placebo 10 mg 3 times a day for 7 days, 2 times a day from day 8 to 10, once a day from day 11 to 12